Literature DB >> 25092501

Pain during Fallopian-tube patency testing by hysterosalpingo-foam sonography.

D Van Schoubroeck1, T Van den Bosch, L Ameye, A S Boes, T D'Hooghe, D Timmerman.   

Abstract

OBJECTIVES: To evaluate perception of pain during Fallopian-tube patency testing by hysterosalpingo-foam sonography (HyFoSy).
METHODS: In this cross-sectional study, 216 consecutive women presenting at a university fertility clinic for HyFoSy examination were included. Patients were instructed to take ibuprofen 1 hour before the procedure. Immediately after the procedure, patients filled in a questionnaire concerning discomfort or pain experienced during the process, including a visual analog scale (VAS) score for perception of pain.
RESULTS: The median VAS score for perception of pain during transvaginal ultrasound examination and during HyFoSy examination was 1.5 (95% CI, 1.2-1.7) and 3.6 (95% CI, 3.0-4.0), respectively. One-third of women reported that the level of discomfort or pain during HyFoSy examination was similar to that during the preceding transvaginal ultrasound examination and 48% of women considered HyFoSy examination to be neutral/unpleasant, but not painful. There was an inverse association between both patients' age and parity and the pain experienced.
CONCLUSIONS: HyFoSy examination is tolerated well and allows for reliable tubal patency testing without exposing the patient to ionizing radiation in an outpatient setting with a low technical failure rate.
Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Fallopian-tube patency tests; female; infertility; microbubbles; ultrasonography

Mesh:

Substances:

Year:  2015        PMID: 25092501     DOI: 10.1002/uog.14646

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  6 in total

Review 1.  Modern assessment of the uterine cavity and fallopian tubes in the era of high-efficacy assisted reproductive technology.

Authors:  Kate Devine; Shelley Dolitsky; Inga Ludwin; Artur Ludwin
Journal:  Fertil Steril       Date:  2022-07       Impact factor: 7.490

Review 2.  Hysterosalpingo-foam sonography: patient selection and perspectives.

Authors:  Hemashree Rajesh; Serene Liqing Lim; Su Ling Yu
Journal:  Int J Womens Health       Date:  2016-12-28

Review 3.  Clinical Aspects of HyFoSy as Tubal Patency Test in Subfertility Workup.

Authors:  Niek Exalto; Mark Hans Emanuel
Journal:  Biomed Res Int       Date:  2019-07-08       Impact factor: 3.411

4.  Live birth after additional tubal flushing with oil-based contrast versus no additional flushing: a randomised, multicentre, parallel-group pragmatic trial in infertile women with at least one patent tube at hysterosalpingo-foam sonography (HYFOIL study).

Authors:  Diane De Neubourg; Lara Janssens; Iris Verhaegen; Elke Smits; Ben W Mol; Ella Roelant
Journal:  BMJ Open       Date:  2021-11-29       Impact factor: 2.692

5.  Can hysterosalpingo-foam sonography replace hysterosalpingography as first-choice tubal patency test? A randomized non-inferiority trial.

Authors:  Nienke van Welie; Joukje van Rijswijk; Kim Dreyer; Machiel H A van Hooff; Jan Peter de Bruin; Harold R Verhoeve; Femke Mol; Wilhelmina M van Baal; Maaike A F Traas; Arno M van Peperstraten; Arentje P Manger; Judith Gianotten; Cornelia H de Koning; Aafke M H Koning; Neriman Bayram; David P van der Ham; Francisca P J M Vrouenraets; Michaela Kalafusova; Bob I G van de Laar; Jeroen Kaijser; Arjon F Lambeek; Wouter J Meijer; Frank J M Broekmans; Olivier Valkenburg; Lucy F van der Voet; Jeroen van Disseldorp; Marieke J Lambers; Rachel Tros; Cornelis B Lambalk; Jaap Stoker; Madelon van Wely; Patrick M M Bossuyt; Ben Willem J Mol; Velja Mijatovic
Journal:  Hum Reprod       Date:  2022-05-03       Impact factor: 6.353

6.  Evaluation of the safety and effectiveness of tubal inflammatory drugs in patients with incomplete tubal obstruction after four-dimensional hysterosalpingo-contrast-sonography examination.

Authors:  Yue Zhang; Qin Wang; Chun-Yan Gao; Hong-Ju Tian; Wen-Jiao He; Xi Zhang; Xi Xiong
Journal:  BMC Pregnancy Childbirth       Date:  2022-05-07       Impact factor: 3.105

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.